Key facts
- This page summarizes Thomas J. Wilson's Form 4 filing for ALLSTATE CORP (ALL).
- 4 reported transactions and 9 derivative rows are listed below.
- Accepted by SEC: 17 Dec 2025, 16:03.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Sale
Sale
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $207.725 to $208.690. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
Footnote F2
The sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on June 27, 2025.
Footnote F3
Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $208.825 to $209.780. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
Footnote F4
Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $209.835 to $210.8275. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
Footnote F5
Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $210.840 to $211.145. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
Footnote F6
Reflects transfer of 68,216 vested employee options to TJW Options LLC 2022 Series Last Third on December 12, 2025, formerly held directly by the reporting person.
Footnote F7
Stock option award granted on February 16, 2023 for 157,835 shares of common stock exercisable in three increments. The remaining increment will vest on February 16, 2026.
Footnote F8
Reflects transfer of 52,612 vested employee options to TJW Options LLC 2023 Series Middle Third on December 12, 2025, formerly held directly by the reporting person. 52,612 unvested employee options remain directly held.
Footnote F9
Stock option award granted on February 21, 2024, for 119,784 shares of common stock vesting in three equal increments. The remaining increments will vest on February 21, 2026 and February 21, 2027.
Footnote F10
Reflects transfer of 39,928 vested employee options to TJW Options LLC 2024 Series First Third on December 12, 2025, formerly held directly by the reporting person. 79,856 unvested employee options remain directly held.